8.16

5.23% -0.45

Pre-market: 7.79 -0.37 -4.53%

Precision Biosciences Inc (DTIL)

Overview News Price History Option Chain Financials Discussions Forecast

Precision Biosciences Inc stock is traded at $8.16, with a volume of 142.15K. It is down -5.23% in the last 24 hours and up +47.83% over the past month. Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Previous Close:

$8.61

Open:

$8.64

24h Volume:

142.15K

Relative Volume:

1.26

Market Cap:

$96.18M

Revenue:

$52.29M

Net Income/Loss:

$-73.52M

P/E Ratio:

-12.36

EPS:

-0.66

Net Cash Flow:

$-100.45M

1W Performance:

+21.43%

1M Performance:

+47.83%

6M Performance:

+44.68%

1Y Performance:

-4.67%

1-Day Range:

$8.0001

$8.77

1-Week Range:

$6.63

$8.82

52-Week Range:

$3.61

$9.14

Precision Biosciences Inc Stock (DTIL) Company Profile

Name

Precision Biosciences Inc

Sector

Healthcare (1135)

Industry

Biotechnology (635)

Phone

919-314-5512

Address

302 EAST PETTIGREW STREET, DURHAM, NC

Employee

102

Twitter

@PrecisionBioSci

Next Earnings Date

2024-11-04

Latest SEC Filings

DTIL's Discussions on Twitter

Compare DTIL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DTIL Precision Biosciences Inc	8.16	101.49M	52.29M	-73.52M	-100.45M	-0.66
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-10-25	Upgrade	BMO Capital Markets	Market Perform → Outperform
Apr-30-24	Initiated	Guggenheim	Buy
Jun-17-22	Initiated	BMO Capital Markets	Outperform
Jun-09-22	Downgrade	William Blair	Outperform → Mkt Perform
Jul-27-20	Resumed	BTIG Research	Buy
Apr-03-20	Downgrade	Goldman	Buy → Neutral
Mar-05-20	Initiated	Stifel	Buy
Feb-25-20	Initiated	William Blair	Outperform
Aug-09-19	Initiated	BTIG Research	Buy
Jul-16-19	Initiated	H.C. Wainwright	Buy
Apr-22-19	Initiated	Barclays	Overweight
Apr-22-19	Initiated	Goldman	Buy
Apr-22-19	Initiated	JP Morgan	Overweight
Apr-22-19	Initiated	Jefferies	Buy

View All

Precision Biosciences Inc Stock (DTIL) Latest News

07:37 AM

Precision BioSciences Inc Reports Q3 2025 EPS of -$1.84, Missing - GuruFocus

07:37 AM

07:30 AM

Precision BioSciences: Q3 Earnings Snapshot - San Antonio Express-News

07:30 AM

07:01 AM

Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update - FinancialContent

07:01 AM

04:11 AM

Imugene Issues Shares to Precision Biosciences, Marking Milestone Achievement - TipRanks

04:11 AM

03:55 AM

Imugene Issues Shares to Precision Biosciences Following Milestone Achievement - TipRanks

03:55 AM

02:38 AM

How Precision BioSciences Inc. stock trades during market volatilityTrade Risk Assessment & Weekly High Conviction Ideas - newser.com

02:38 AM

02:15 AM

Is Precision BioSciences Inc. stock a defensive play in 2025July 2025 Decliners & Fast Exit and Entry Strategy Plans - newser.com

02:15 AM

01:40 AM

Can Precision BioSciences Inc. stock resist market sell offsWeekly Profit Summary & Long-Term Capital Growth Strategies - newser.com

01:40 AM

Nov 02, 2025

Using economic indicators to assess Precision BioSciences Inc. potentialJuly 2025 Summary & Real-Time Market Sentiment Reports - newser.com

Nov 02, 2025

Imugene to explore discussions with FDA, triggering Precision BioSciences milestone - Proactive financial news

Nov 02, 2025

Multi asset correlation models including Precision BioSciences Inc.Trade Exit Summary & Daily Technical Stock Forecast Reports - newser.com

Nov 02, 2025

Real time breakdown of Precision BioSciences Inc. stock performanceMarket Performance Report & Reliable Breakout Forecasts - newser.com

Nov 02, 2025

Nov 01, 2025

Detecting price anomalies in Precision BioSciences Inc. with AIJuly 2025 Price Swings & Capital Efficient Trade Techniques - newser.com

Nov 01, 2025

Oct 31, 2025

Precision BioSciences, Inc. (NASDAQ:DTIL) Short Interest Update - MarketBeat

Oct 31, 2025

Is Precision BioSciences Inc. (PBS0) stock prepared for digital transitionPortfolio Update Report & High Yield Stock Recommendations - newser.com

Oct 31, 2025

Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025 - BioSpace

Oct 31, 2025

Will Precision BioSciences Inc. outperform the marketVolume Spike & Community Trade Idea Sharing - newser.com

Oct 31, 2025

Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns climbed after last week's 24% gain, institutional investors must be happy - Yahoo Finance

Oct 31, 2025

A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy - simplywall.st

Oct 31, 2025

Is Precision BioSciences Inc. stock positioned well for digital economyQuarterly Profit Summary & Verified Entry Point Signals - newser.com

Oct 31, 2025

Is Precision BioSciences Inc. (PBS0) stock a top dividend aristocrat candidateJuly 2025 Earnings & Daily Market Momentum Tracking - newser.com

Oct 31, 2025

Earnings visualization tools for Precision BioSciences Inc.July 2025 EndofMonth & Weekly Setup with High ROI Potential - newser.com

Oct 31, 2025

Is Precision BioSciences Inc. stock gaining market shareJuly 2025 Update & AI Driven Stock Reports - newser.com

Oct 31, 2025

Momentum divergence signals in Precision BioSciences Inc. chartWeekly Stock Report & High Accuracy Swing Entry Alerts - newser.com

Oct 31, 2025

Oct 30, 2025